Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 26,086 calls trading, 1.1x expected, and implied vol increasing almost 32 points to 119.88%. 10/31 weekly 6 calls and Oct-25 5.5 calls are the most active options, with total volume in those strikes near 7,800 contracts. The Put/Call Ratio is 0.14. Earnings are expected on November 6th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals rises 17.9%
- Unusually active option classes on open September 25th
- Strategic Growth and Unique Positioning Drive Buy Rating for Recursion Pharmaceuticals
- Recursion Pharmaceuticals management to meet with Needham
- Buy Recommendation for Recursion Pharmaceuticals: Strong Position in AI-Driven Drug Discovery with Strategic Acquisitions and Financial Stability